home / stock / enz / enz news


ENZ News and Press, Enzo Biochem Inc. From 12/15/23

Stock Information

Company Name: Enzo Biochem Inc.
Stock Symbol: ENZ
Market: NYSE
Website: enzo.com

Menu

ENZ ENZ Quote ENZ Short ENZ News ENZ Articles ENZ Message Board
Get ENZ Alerts

News, Short Squeeze, Breakout and More Instantly...

ENZ - ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE

FARMINGDALE, NY, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the first quarter ended October 31, 2023. First Quarter Highlights The Company's Life Sciences division's fir...

ENZ - Expected US Company Earnings on Monday, December 11th, 2023

Lanvin Group Holdings Limited (LANV) is expected to report for quarter end 2023-09-30 Sonnet BioTherapeutics Holdings Inc. (SONN) is expected to report for Q4 2023 Shionogi & Co. Ltd. ADR (SGIOY) is expected to report for Q2 2024 Gelesis Holdings, Inc. (GLSHQ) is expected to repor...

ENZ - Jackson Peak Capital Q3 2023  Update

2023-11-11 02:30:00 ET Summary Jackson Peak is an alternative investment firm that manages a single, concentrated, long / short equity portfolio. The firm’s objective is to deliver attractive risk-adjusted, absolute returns. In Q3 2023, Jackson Peak returned +11.8% despite ...

ENZ - Enzo Biochem GAAP EPS of $0.41

2023-11-06 13:36:11 ET More on Enzo Biochem Enzo Biochem: Cleaned Up And Cash-Rich But Unloved Enzo Biochem names interim CEO Financial information for Enzo Biochem For further details see: Enzo Biochem GAAP EPS of $0.41

ENZ - ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE

FARMINGDALE, NY, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fourth quarter ended July 31, 2023, and the fiscal year ended July 31, 2023, and also provided a general business updat...

ENZ - Steven J. Pully Appointed to Enzo Biochem's Board of Directors

FARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) --  Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Company’s Board of Directors effective October 26, 2...

ENZ - Expected US Company Earnings on Friday, October 27th, 2023

FNCB Bancorp Inc. (FNCB) is expected to report for Q1 2024 Civista Bancshares Inc. (CIVB) is expected to report $0.6 for Q3 2023 ASLAN Pharmaceuticals Limited (ASLN) is expected to report $-0.85 for Q3 2023 Grupo Televisa S.A. (TV) is expected to report $0.02 for Q3 2023 Red River...

ENZ - Enzo Biochem: Cleaned Up And Cash-Rich But Unloved

2023-10-26 01:18:21 ET Summary Enzo Biochem is a microcap company with a $30 million revenue run-rate Life Sciences business and $78-$85 million in cash. The company is likely being prepared for sale, with interest from potential acquirers and activists controlling 30% of voting s...

ENZ - Expected US Company Earnings on Friday, October 20th, 2023

South Plains Financial Inc. (SPFI) is expected to report $0.64 for Q3 2023 Grupo Aeroportuario Del Pacifico S.A. B. de C.V. de C.V. (each representing 10 Series B shares) (PAC) is expected to report $3.13 for Q3 2023 Himalaya Technologies Inc (HMLA) is expected to report for Q1 2024 R...

ENZ - Expected US Company Earnings on Friday, October 13th, 2023

JPMorgan Chase & Co. (JPM) is expected to report $3.89 for Q3 2023 Unity Bancorp Inc. (UNTY) is expected to report $0.89 for Q3 2023 Wells Fargo & Company (WFC) is expected to report $1.25 for Q3 2023 Intellipharmaceutics International Inc (IPCIF) is expected to report for Q1 ...

Previous 10 Next 10